Stay updated on Amgen Press Releases

Sign up to get notified when there's something new on the Amgen Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Amgen Press Releases page

  1. Check
    7 days ago
    Change Detected
    Summary
    AMGEN has announced its 2025 first quarter dividend.
    Difference
    16%
    Check dated 2024-12-14T22:30:39.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Amgen has made significant announcements, including the addition of BLINCYTO® for pediatric B-ALL treatment, a $1 billion manufacturing expansion in North Carolina, and positive results for various drugs in clinical trials, highlighting advancements in oncology and rare diseases.
    Difference
    100%
    Check dated 2024-12-07T15:50:34.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Amgen has made significant announcements regarding new data presentations and executive appointments, while notable deletions include various financial results and conference presentations from late 2024.
    Difference
    100%
    Check dated 2024-11-30T12:23:17.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Amgen has announced several significant updates, including a senior executive research appointment, new data presentations at major conferences, and the approval of Tepezza® in Japan for active thyroid eye disease.
    Difference
    100%
    Check dated 2024-11-23T04:31:01.000Z thumbnail image
  5. Check
    65 days ago
    Change Detected
    Summary
    Amgen has recently presented positive Phase 3 data for Uplizna® in generalized myasthenia gravis and received approval for Tepezza® in Japan for active thyroid eye disease, highlighting significant advancements in their clinical research and product offerings.
    Difference
    100%
    Check dated 2024-10-17T18:50:05.000Z thumbnail image
  6. Check
    94 days ago
    Change Detected
    Summary
    Amgen has made significant updates, including the FDA approval of IMDELLTRA™ for extensive-stage small cell lung cancer and the launch of OTEZLA® for pediatric plaque psoriasis, while several upcoming presentations and financial results have been removed from the site.
    Difference
    100%
    Check dated 2024-09-18T16:26:13.000Z thumbnail image

Stay in the know with updates to Amgen Press Releases

Enter your email address, and we'll notify you when there's something new on the Amgen Press Releases page.